RSC Medicine Accepted Manuscript, Chem., 2023
DOI: 10.1039/D3MD00190C, Research ArticlePiet Herdewijn, Chao Liu, Li Xin Zhang, Mengmeng Wang, Kunyu Qu, Peipei Zhao, and Yiwei Mang are some of the names.
Gemcitabine is an antimetabolite drug that has been approved for the treatment of many cancers, but its use is constrained because of a number of problems, including drug resistance, toxicity, and stability. Here, we …
The Royal Society of Chemistry’s RSS Feed( c ) content
Synthesis and Anticancer Evaluation of Acetylated-Lysine Conjugated Gemcitabine Prodrugs
